Clinical Trial Update: A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP [Phase 3]

View source ↗

Summary

Phase 3b randomized, double-blind study evaluating safety and efficacy of omadacycline versus moxifloxacin for community-acquired bacterial pneumonia; recruitme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Bacterial Pneumonia

Drugs mentioned

• Moxifloxacin (moxifloxacin)
• Omadacycline (omadacycline)

Snippet

Sponsor: Zai Lab (Hong Kong), Ltd. | Conditions: Community-acquired Bacterial Pneumonia | Phase 3 | Status: RECRUITING